DR. TOM THOMAS
ActiveDR. TOM THOMAS has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €659k and a net result of €117k. Equity is growing by ~12.1% per year across the filed fiscal years. Its solvency ranks better than 94% of 16527 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
96
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability90▼-1
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €60k at 30 days acceptable
Liquidity ample (current ratio 24.22 against 19.62 in 2024; short-term debt: 3.5% and cash: 35.8% of total assets), and 3.5% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
96.5%
Return on assets
17.2%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 18-08-2026, 18 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
18 d late
2024
26 d late
2023
30 d late
2022
31 d late
2021
31 d late
2020
31 d late
2019
59 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
22-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€659k▲ 9.4%
2024 · €602k
2018: €244k
2019: €305k
2020: €403k
2021: €454k
2022: €523k
2023: €565k
2024: €602k
2018 → 2025
Total assets
€683k▲ 8.6%
2024 · €629k
2018: €268k
2019: €356k
2020: €429k
2021: €483k
2022: €561k
2023: €590k
2024: €629k
2018 → 2025
Net result
€117k▲ 4.9%
2024 · €112k
2018: €74k
2019: €96k
2020: €98k
2021: €104k
2022: €101k
2023: €112k
2024: €112k
2018 → 2025
Working capital
€556k▲ 12.9%
2024 · €493k
2018: €228k
2019: €210k
2020: €231k
2021: €305k
2022: €391k
2023: €447k
2024: €493k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€454k-€523k▲ 15.3%€565k▲ 8.0%€602k▲ 6.7%€659k▲ 9.4%
Operating result€149k-€144k▼ 3.2%€160k▲ 11.1%€159k▼ 0.3%€168k▲ 5.2%
Net result€104k-€101k▼ 3.0%€112k▲ 10.7%€112k▲ 0.1%€117k▲ 4.9%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 5% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €683k
Fixed assets
€103k▼ 6.0%
Current assets
€580k▲ 11.7%
Equity and liabilities €683k
Equity
€659k▲ 9.4%
Debt
€24k▼ 9.5%
The debt ratio falls from 4.2% to 3.5%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€175k▲
2024 · €168k
Cash flow
€125k▲
2024 · €120k
Solvency
96.5%▲
2024 · 95.8%
Current ratio
24.22▲
2024 · 19.62
Quick ratio
24.22▲
2024 · 19.62
Debt / equity
0.04▼
2024 · 0.04
ROE
17.8%▼
2024 · 18.6%
ROA
17.2%▼
2024 · 17.8%
Interest coverage
1298.31▲
2024 · 950.50
Debt
€24k▼
2024 · €26k
Debt ≤ 1 year
€24k▼
2024 · €26k
Income taxes
€51k▲
2024 · €48k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€629k€683k▲
Fixed assets21/28€110k€103k▼
Tangible fixed assets22/27€110k€103k▼
Land and buildings22€108k€101k▼
Furniture and vehicles24€1k€2k▲
Current assets29/58€519k€580k▲
Amounts receivable within one year40/41€32k€33k▲
Trade receivables40€32k€31k▼
Other amounts receivable41€13€2k▲
Current investments50/53€300k€300k=
Cash at bank and in hand54/58€185k€244k▲
Deferred charges and accrued income490/1€3k€2k▼
Equity and liabilities
Total equity and liabilities10/49€629k€683k▲
Equity10/15€602k€659k▲
Contributions10/11€12k€12k=
Reserves13€590k€647k▲
Non-distributable reserves130/1€2k€2k=
Reserves not available under the articles1311€2k€2k=
Distributable reserves133€588k€645k▲
Profit (loss) carried forward14€0€0=
Amounts payable17/49€26k€24k▼
Amounts payable within one year42/48€26k€24k▼
Financial debts43€173€0▼
Credit institutions430/8€173€0▼
Trade debts44€541€101▼
Suppliers440/4€541€101▼
Taxes, remuneration and social security45€26k€23k▼
Taxes450/3€26k€23k▼
Other amounts payable47/48-€618
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€9k€8k▼
Other operating charges640/8€2k€2k▲
Non-recurring operating charges66A-€1k
Gross operating margin9900€170k€179k▲
Operating profit (loss)9901€159k€168k▲
Financial income75/76B€500€898▲
Recurring financial income75€500€898▲
Financial charges65/66B€177€135▼
Recurring financial charges65€177€135▼
Profit (loss) for the period before taxes9903€160k€168k▲
Income taxes67/77€48k€51k▲
Profit (loss) for the period9904€112k€117k▲
Profit (loss) for the period to be appropriated9905€112k€117k▲
Appropriation of the result
Profit (loss) to be appropriated9906€112k€117k▲
Transfer from equity791/2€74k€60k▼
Transfer to equity691/2€112k€117k▲
To other reserves6921€112k€117k▲
Profit to be distributed694/7€74k€60k▼
Return on contributions (dividend)694€74k€60k▼
The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
18-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 18 days late
2025
31-12
Financial
Highest result since 2018net €117k ▲4.9%
Operating result €168k, net result €117k, both a record.
26-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 26 days late
2024
30-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 30 days late
2023
31-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 31 days late
2022
31-12
Financial
Equity above €500kEq €523k ▲15.3%
5 profitable years in a row build equity to €523k.
31-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 31 days late
2021
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 31 days late
2020
28-09
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 59 days late
2019
04-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
02-07
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
03-07
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Zoersel · 2 establishment units since 2008
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Heidehoeven 392980 ZoerselGround area
1,895 m²
Building footprint
388 m²
Volume, LiDAR
2,015 m³
2 parcels, Flanders · tallest building 9.5 m, ±2 floors. Linked by address, not a title deed.
2 establishment units
DR. TOM THOMAS
since 20082.193.834.746
Dr. Tom Thomas
since 20202.324.293.016
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11017A0601/00E000 | Flanders | 1,550 m² | 1 · 240 m² | 9.5 m · 2 fl. |
| 11017B0099/00T000 | Flanders | 345 m² | 1 · 147 m² | 9.1 m · 1 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
DR. REFAT SHARAFEDIN, ALGEMENE GENEESKUNDE
BE 0836.671.322
Brussel · Eq €660k
DR. ST. BRESSELEERS
BE 0468.885.033
Wijnegem · Eq €659k
ESENOL
BE 0842.351.661
Tubize · Eq €660k
MAISON MEDICALE 1190
BE 0839.558.754
Vorst · Eq €658k
DOKTER MERTENS PIETER
BE 0844.882.173
Zonhoven · Eq €660k
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 4,637 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company (pre-2019)
Founded02-07-2008
Fiscal year end31-12
Activities, NACEBEL
86210General medical practice
68203Renting and operating of own or leased non-residential real estate, excluding land
Sources
Crossroads Bank for EnterprisesNational Bank · 17 filingsAddress and cadastre registers
Data from official sources, last processed on 20-09-2026. Scores and ratios are computed by Checked and are not a credit decision.